Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVO.L Regulatory News (AVO)

  • There is currently no data for AVO

Acquisition

11 Dec 2006 07:01

CareCapital Group plc11 December 2006 For release at 0700h, 11 December 2006 CareCapital Group Plc ("CareCapital" or "the Company") Investment and Development Programme in Germany CareCapital Group Plc, the healthcare real estate company which listed on AIM inAugust (CARE), announces that it has completed the acquisition of a majormedical centre in Berlin as the first part of an initial €35 million investmentand development programme in Germany. This first investment, at an acquisition cost of • 9.2 million, is a 4,100 sq mmedical facility housing 34 tenants including physicians, dentists, a dentallab, diagnostic facilities, a pharmacy and other healthcare related retailers.An additional €4.2 million acquisition of a 2,800 sq m medical centre housing 25medical tenants situated to the South East of Berlin together with its adjoiningdevelopment site is scheduled for completion in February 2007. These two investments represent the initial stage of the €35 million programme,on which heads of terms have been agreed with a German developer/constructioncompany, with funding supplied by a major German bank. The programme currentlyincludes two further development sites in the Berlin area. Any additionalfunding for the programme will come from the Company's existing resources andfacilities. The programme enables CareCapital to capitalise on recent changes in Germanlegislation which favour primary care provision from large, integrated medicalcare centres. Michael Sinclair, Chairman, commented: "The investment and development programmein Germany follows extensive research, conducted by CareCapital over the pastmonths and represents an exciting opportunity for the Company. It will notimpact on our development programme in the UK which remains on target. "CareCapital will leverage its UK experience to manage and develop the mixedeconomy healthcare facilities in Germany that will increasingly become a featureof UK primary care provision as services are moved out of the hospitalenvironment to community locations in accordance with Government policy. Inaddition, the programme will bring us high quality assets at yieldssignificantly greater than those currently prevailing in the UK and withsimilarly comparable covenant profiles." For further information please visit www.carecapital.co.uk or contact: CareCapital Group Plc Daniel Stewart & Co. Plc Tavistock CommunicationsPaul Stacey, Managing Director Lindsay Mair, Director - Simon Hudson,Shareen Courtney, Marketing Corporate Finance Richard SunderlandTel: 020 7034 1949 Tel: 020 7776 6550 Tel: 020 7920 3150pstacey@carecapital.co.uk lindsay.mair@danielstewart.co.uk shudson@tavistock.co.ukscourtney@carecapital.co.uk rsunderland@tavistock.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Mar 20225:05 pmRNSDirector/PDMR Notification
2nd Mar 20224:10 pmRNSDirector/PDMR Notification
1st Mar 20227:00 amRNSOperational update
28th Feb 20225:00 pmRNSTotal Voting Rights
17th Feb 20224:25 pmRNSExercise of Warrants and Issue of Equity
31st Jan 20225:00 pmRNSTotal Voting Rights
13th Jan 20223:17 pmRNSExercise of Warrants and Issue of Equity
31st Dec 20211:00 pmRNSTotal Voting Rights
13th Dec 20217:00 amRNSTechnical update on delivery of first LIGHT system
10th Dec 20217:00 amRNSHolding(s) in Company
3rd Dec 20215:09 pmRNSHolding(s) in Company
2nd Dec 20211:29 pmRNSIssue of warrants and equity and Loan Extension
30th Nov 20215:00 pmRNSTotal Voting Rights
15th Nov 20218:30 amEQSHardman & Co Research: Advanced Oncotherapy (AVO): On the home straight
10th Nov 202111:23 amRNSHolding(s) in Company
8th Nov 20212:28 pmRNSExercise of Warrants and Issue of Equity
4th Nov 20211:44 pmRNSHolding(s) in Company
27th Oct 20217:00 amRNSPresentation highlights LIGHT system superiority
30th Sep 20215:00 pmRNSTotal Voting Rights
30th Sep 20217:00 amRNSInterim Results
23rd Sep 202111:27 amRNSExercise of Warrants and Issue of Equity
20th Sep 20217:00 amRNSUpdate re admission of Subscription Shares
3rd Sep 20217:00 amRNSUpdate on admission of Subscription Shares
31st Aug 20216:14 pmRNSResult of GM, TVR and clarification re warrants
16th Aug 20214:48 pmRNSExercise of Warrants and Issue of Equity
12th Aug 20211:50 pmEQSHardman & Co Research: Advanced Oncotherapy (AVO) Funded to completion
11th Aug 20217:00 amRNSProposed subscription and issuance of shares
2nd Aug 20213:37 pmRNSResult of AGM
30th Jul 20214:58 pmRNSResult of AGM
13th Jul 20212:19 pmRNSHoldings in company
30th Jun 20217:00 amRNSFinal Results for the year ended 31 December 2020
3rd Jun 20217:00 amRNSSaba Partners sign LOI for LIGHT system
28th May 20215:00 pmRNSTotal Voting Rights
26th May 202110:37 amRNSExercise of Warrants and Issue of Equity
28th Apr 20215:38 pmRNSExercise of Warrants and Issue of Equity
31st Mar 20215:00 pmRNSTotal Voting Rights
12th Mar 20217:00 amRNSStudy shows the potential superiority of LIGHT
11th Mar 20217:00 amRNSExercise of Warrants and Issue of Equity
26th Feb 20215:00 pmRNSTotal Voting Rights
17th Feb 202110:39 amRNSExercise of Warrants and Issue of Equity
22nd Jan 20217:00 amRNSEquity fundraise of c.£5.9m
13th Jan 20217:00 amRNSExercise of Warrants and Issue of Equity
11th Jan 20217:00 amRNSTechnical update
6th Jan 202111:05 amRNSSecond Price Monitoring Extn
6th Jan 202111:00 amRNSPrice Monitoring Extension
6th Jan 20217:00 amRNSFinancing partnership agreement with DiaMedCare AG
15th Dec 20207:15 amEQSHardman & Co Research: Advanced Oncotherapy (AVO): Leveraging the modularity of LIGHT
23rd Nov 20202:42 pmRNSHolding(s) in Company
17th Nov 20202:02 pmRNSHolding(s) in Company
10th Nov 20207:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.